Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

Clinical trial NCT05224388 · COMPLETED

Trial details

NCT number: NCT05224388
Sponsor: University Hospital, Ghent
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Deep Vein Thrombosis Anticoagulants and Bleeding Disorders Critical Illness

Start date: 2020-01-01
Primary completion: 2021-08-31
Enrollment: 813

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.